4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
This section summarizes market dynamics, key shifts, and high-impact trends shaping demand outlook.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL DENTAL IMPLANTS AND PROSTHETICS INDUSTRY
5.2.4
TRENDS IN GLOBAL DENTAL IMAGING INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND, BY PRODUCT (2022-2024)
5.6.2
AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2022-2024)
5.8
KEY CONFERENCES AND EVENTS, 2025–2026
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF – PERIODONTAL DISEASE TREATMENT MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON PERIODONTAL DISEASE TREATMENT MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN PERIODONTAL DISEASE TREATMENT MARKET
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN THE PERIODONTAL DISEASE TREATMENT MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PERIODONTAL DISEASE TREATMENT MARKET
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT (2024 TO 2031, USD MILLION & VOLUME, IN UNITS)
10
PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE TYPE (2024 TO 2031, USD MILLION)
10.3
CHRONIC PERIODONTITIS
10.4
AGGRESSIVE PERIODONTITIS
10.5
OTHERS (NECROTIZING PERIODONTITIS, PERIODONTAL ABSCESS, SYSTEMIC PERIODONTITIS)
11
PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE (2024 TO 2031, USD MILLION)
11.2
NON-SURGICAL TREATMENT
11.2.3
MEDICATION THERAPY
11.2.3.2
SYSTEMIC THERAPY
11.3
FLAB SURGERY/POCKET REDUCTION THERAPY
11.6
GUIDED TISSUE REGENERATION
(* THE MARKET SIZE ESTIMATION WILL BE BASED ONLY ON THE USE/SALES OF INSTRUMENTS, DEVICES, AND CONSUMABLES FOR THE ABOVE-STATED SURGERIES. THE OTHER COSTS, SUCH AS PHYSICIAN FEES AND OTHER TREATMENT COSTS, ARE NOT CONSIDERED IN THE MARKET ANALYSIS.
12
PERIODONTAL DISEASE TREATMENT MARKET, BY END USER (2024 TO 2031, USD MILLION)
12.3
PRIVATE & DSO CLINICS
12.4
ACADEMIC & RESEARCH INSTITUTIONS
13
PERIODONTAL DISEASE TREATMENT MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
13.4.6
REST OF ASIA PACIFIC
13.5.3
REST OF LATIN AMERICA
13.6
MIDDLE EAST & AFRICA
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
14.3
REVENUE ANALYSIS, 2020-2024
14.4
MARKET SHARE ANALYSIS,
14.5
BRAND/PRODUCT COMPARATIVE ANALYSIS
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.6.5.1
COMPANY FOOTPRINT
14.6.5.2
PRODUCT FOOTPRINT
14.6.5.3
DISEASE TYPE FOOTPRINT
14.6.5.3
TREATMENT TYPE FOOTPRINT
14.6.5.4
END-USER FOOTPRINT
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.7.1
PROGRESSIVE COMPANIES
14.7.2
RESPONSIVE COMPANIES
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
14.8
COMPETITIVE SCENARIO
14.8.4
OTHER DEVELOPMENTS
14.9
COMPANY VALUATION AND FINANCIAL METRICS
15.1.2
ENVISTA HOLDINGS CORPORATION
15.1.3
INSTITUT STRAUMANN AG
15.1.4
HENRY SCHEIN, INC.
15.1.6
GEISTLICH PHARMA AG
15.1.11
YOSHIDA DENTAL MFG.CO.LTD
15.1.12
KEYSTONE DENTAL INC
15.1.13
ULTRADENT PRODUCTS, INC
15.1.14
BEGO GMBH & CO.KG
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
BASE NUMBER CALCULATION
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
17.1
INSIGHTS OF INDUSTRY EXPERTS
17.3
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.4
AVAILABLE CUSTOMIZATION
Growth opportunities and latent adjacency in Periodontal Disease Treatment Market